Israeli drug maker Teva Pharmaceutical Industries Ltd. is buying La Jolla-based Auspex Pharmaceuticals Inc. in a deal valued at about $3.2 billion, increasing Teva’s presence among treatments for central nervous system disorders, the Wall Street Journal reports.
11150 Santa Monica Boulevard, Suite 350
Los Angeles, CA 90025
323-549-5225
© Los Angeles Business Journal